The diagnostics advisory committee considered evidence on FibroScan for assessing liver fibrosis and cirrhosis from several sources, including an external assessment report and an overview of that ...

FibroScan® Pro无创肝脏诊断设备作为一款创新性的设备，凭借其先进的振动控制瞬时弹性成像技术（VCTE™）和受控衰减参数技术（CAP™），已经在全球范围内广泛应用于肝病的诊断与管理。该设备不仅能够提供肝脏硬度的精确测量，还能够评估肝脏脂肪变性和门 ...

WALTHAM, Mass.--(BUSINESS WIRE)--Echosens, a high-technology company offering the FibroScan family of products, today announces the release of its white paper, “FibroScan Technology Assesses and ...

PARIS and WALTHAM, Mass., March 22, 2023 /PRNewswire/ -- The U.S. Food and Drug Administration (FDA) has cleared expanded Indications for Use for screening with FibroScan®, the non-invasive liver ...

This article is brought to you by Our Lady of the Angels. An innovative non-invasive technology at Our Lady of the Angels is helping doctors better detect liver problems, leading to earlier treatment ...